Skip to main content

Table 5 Association between alcohol drinking and gout among participants with the ALDH2 rs671 GA+AA genotype stratified by BMI

From: Risk of gout among Taiwanese adults with ALDH-2 rs671 polymorphism according to BMI and alcohol intake

Variables

GA+AA genotype (n = 4593)

Normal (n = 2216)

Abnormal (n = 2377)

OR

95% CI

p-value

OR

95% CI

p-value

Alcohol drinking (ref, no)

 Yes

2.109

1.202–3.699

0.0092

1.108

0.789–1.557

0.5525

Sex (ref, women)

 Men

2.561

1.854–3.539

< 0.0001

2.190

1.724–2.780

< 0.0001

Age group (ref, 30–40 years)

 41–50

1.119

0.766–1.635

0.5601

0.664

0.514–0.857

0.0017

 51–60

1.329

0.905–1.951

0.1469

0.743

0.572–0.965

0.0260

 61–70

1.536

0.991–2.382

0.0552

0.589

0.433–0.803

0.0008

Waist-hip ratio (ref, normal)

 Abnormal

1.410

1.063–1.869

0.0171

1.441

1.176–1.766

0.0004

Body fat (ref, normal)

 Abnormal

1.331

0.955–1.856

0.0913

1.392

1.113–1.742

0.0038

Cigarette smoking status (ref, never)

 Former

0.527

0.326–0.851

0.0088

0.950

0.725–1.243

0.7065

 Current

0.890

0.580–1.365

0.5936

0.591

0.438–0.798

0.0006

Coffee consumption (ref, no)

 Yes

0.955

0.720–1.268

0.7516

0.996

0.820–1.211

0.9712

Tea consumption (ref, no)

 Yes

1.562

1.193–2.046

0.0012

1.150

0.953–1.387

0.1454

Exercise (ref, no)

 Yes

1.155

0.873–1.527

0.3127

1.024

0.841–1.248

0.8108

Diet status (ref, non-vegetarian)

 Former vegetarian

0.443

0.200–0.979

0.0442

1.090

0.721–1.650

0.6821

 Vegan

0.492

0.247–0.980

0.0437

0.765

0.466–1.254

0.2876

Blood urea nitrogen (ref, normal)

 Abnormal

2.231

1.313–3.791

0.0030

1.217

0.792–1.871

0.3696

Creatinine (ref, normal)

 Abnormal

1.715

0.407–7.234

0.4626

10.705

2.082–55.046

0.0045

HDL-C

0.979

0.967–0.991

0.0007

0.979

0.969–0.989

< 0.0001

LDL-C

1.006

1.002–1.010

0.0053

1.006

1.003–1.009

0.0002

Triglycerides

1.004

1.002–1.005

< 0.0001

1.003

1.002–1.004

< 0.0001

  1. BMI body mass index, OR odds ratio, CI confidence interval, ref reference, ALDH2 aldehyde dehydrogenase 2, HDL-C high-density lipoprotein cholesterol, LDC-C low-density lipoprotein cholesterol